XiangQian Lin, based in Singapore, is currently a Chairman and CEO at Esco, bringing experience from previous roles at Carcell Biopharma, Nuevocor, Cargene Therapeutics and Carmine Therapeutics. XiangQian Lin holds a 2006 - 2009 Bachelor of Science in Economics, Finance @ The Wharton School. With a robust skill set that includes Corporate Development, Training, Change Management, Corporate Finance, Medical Devices and more, XiangQian Lin contributes valuable insights to the industry. XiangQian Lin has 4 emails on RocketReach.